Inventiva (IVA) Change in Acquisitions & Divestments (2020 - 2025)
Inventiva's (IVA) quarterly Change in Acquisitions & Divestments came in at -$28.0 million in Q2 2025, down 206.64% quarter-over-quarter from $26.3 million in Q4 2024.
Inventiva (IVA) Change in Acquisitions & Divestments (2020 - 2025) Analysis & Trends
Inventiva's Change in Acquisitions & Divestments history runs 6 years deep, the most recent figure standing at -$28.0 million for Q2 2025.
- On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to -$28.0 million in Q2 2025; TTM through Jun 2025 was -$14.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$154.6 million, down 688.68% from the prior year.
- Change in Acquisitions & Divestments slipped to -$28.0 million in Q2 2025 per IVA's latest filing, from $26.3 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $26.3 million in Q4 2024 and bottomed at -$28.0 million in Q2 2025.
- The 5-year median for Change in Acquisitions & Divestments is $1.1 million (2023), against an average of $2.9 million.
- Across the five-year window, Change in Acquisitions & Divestments plunged 92.96% in 2023 and soared 34771.75% in 2024, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at $6.7 million in 2021, then plunged by 84.14% to $1.1 million in 2022, then plunged by 92.96% to $75315.8 in 2023, then surged by 34771.75% to $26.3 million in 2024, then tumbled by 206.64% to -$28.0 million in 2025.
- Per Business Quant, the three latest IVA Change in Acquisitions & Divestments figures stand at -$28.0 million (Q2 2025), $26.3 million (Q4 2024), and $75315.8 (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,200.25 Bn | 66,199.96 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.75 Bn | 466.96 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.43 Bn | 62.43 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Inventiva | 846.21 Mn | 846.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -28.01 Mn |
| Jun 30, 2025 | -28.01 Mn |
| Dec 31, 2024 | 26.26 Mn |
| Dec 31, 2024 | 26.26 Mn |
| Dec 31, 2023 | 75,315.79 |
| Dec 31, 2023 | 75,315.79 |
| Jun 30, 2023 | 1.14 Mn |
| Jun 30, 2023 | 1.14 Mn |
| Dec 31, 2022 | 1.07 Mn |
| Dec 31, 2022 | 1.07 Mn |
| Jun 30, 2022 | 11.47 Mn |
| Jun 30, 2022 | 11.47 Mn |
| Dec 31, 2021 | 6.74 Mn |
| Dec 31, 2021 | 6.74 Mn |
| Jun 30, 2021 | -1.89 Mn |
| Jun 30, 2021 | -1.89 Mn |
| Mar 31, 2021 | 9.00 Mn |
| Mar 31, 2021 | 9.00 Mn |
| Dec 31, 2020 | 8.75 Mn |
| Dec 31, 2020 | 8.75 Mn |